Department of Dermatology, Bispebjerg Hospital
Copenhagen, 2400, Denmark
NCT Number: NCT06813833
The goal of this observational study is to learn if tape strip for transcriptomic (RNA) analysis and optical coherence tomography (OCT) combined can optimize noninvasive management of basal cell carcinoma (BCC) patients.
The main question of the study is to examine if the combination of these two techniques, transcriptomic and OCT, can improve noninvasive detection of human BCCs.
All included patients will undergo 1) an OCT scan and 2) a tape strip collection for transcriptomic analysis from the same BCC.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Copenhagen, 2400, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Single time point at baseline examination
The association between BCC-specific image marker profiles from OCT and BCC-specific transcriptomic profiles from tape strips, in histopathologically confirmed BCC patients.
Bispebjerg Hospital
Other
Image Markers and Transcriptome Profiles: an Exploratory Study of Optical Coherence Tomography and Tape Strips for Basal Cell Carcinoma
Acronym: RNA-OCT-BCC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07010692
Basal Cell Carcinomas, Carcinoma
New York, United States
View Trial DetailsNCT04389112
Basal Cell Carcinomas, Carcinoma
Bordeaux, France
View Trial DetailsNCT02828111
Abnormalities, Multiple, Basal Cell Carcinomas
Los Angeles, California, United States
View Trial DetailsNCT01463709
Abnormalities, Multiple, Basal Cell Carcinomas
Oakland, California, United States
View Trial Details